COGNITIVE AND BEHAVIORAL PRACTICE, published by Elsevier Science Inc, is a prominent peer-reviewed journal focusing on the rapidly evolving field of clinical psychology. With an ISSN of 1077-7229 and an E-ISSN of 1878-187X, this journal has established itself as a key resource for researchers and practitioners alike since its inception in 1994. As of 2023, it proudly holds a Q1 ranking in the Clinical Psychology category, ranked #85 out of 311 according to Scopus, placing it in the 72nd percentile among its peers. The journal aims to disseminate innovative approaches and evidence-based practices within cognitive and behavioral therapy, encouraging robust discussion and dissemination of new findings to enhance clinical practices. Researchers and students engaged in psychological research will find the substantial rigor and depth in its publications invaluable for advancing their knowledge and skills.

ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH, published by COGNIZANT COMMUNICATION CORP, is a pivotal journal that delves into the intricate relationship between acupuncture, electro-therapeutics, and their applications in the fields of anesthesiology, pain medicine, and complementary therapies. With an ISSN of 0360-1293 and an E-ISSN of 2167-9010, this esteemed journal has been serving the academic community since 1976 and will continue to publish groundbreaking research until 2024. Despite its current positioning within the Q4 quartiles for both anesthesiology and complementary medicine, ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH remains a valuable platform for disseminating innovative studies that push the boundaries of traditional pain management and neuroscience. Researchers, students, and professionals interested in exploring contemporary therapeutic modalities will find this journal an indispensable resource for understanding the efficacy and applications of acupuncture and electro-therapeutics. With a focus on advancing knowledge in these domains, the journal aims to foster a deeper understanding of integrative approaches to health and wellness.

EATING DISORDERS, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing the understanding of eating disorders from diverse psychological, medical, and social perspectives. With an ISSN of 1064-0266 and an E-ISSN of 1532-530X, this journal is recognized for its rigorous peer-reviewed research and innovative studies, contributing significantly to the field of clinical psychology and psychiatry. It boasts impressive rankings, including a Q1 classification in Clinical Psychology and a Q1 classification in Medicine (miscellaneous) based on the 2023 category quartiles. Researchers will find its impactful insights invaluable, as it ranks 31st out of 311 in clinical psychology, placing it in the top 10% percentile. Although this journal is not open access, it encompasses a comprehensive range of topics related to eating disorders, fostering a deeper understanding that benefits practitioners, researchers, and students alike. For those dedicated to addressing the complexities of eating disorders, EATING DISORDERS is an essential resource that bridges the gap between research and real-world application.

JOURNAL OF PSYCHOPHARMACOLOGY, published by SAGE Publications Ltd, is a leading peer-reviewed journal that explores the intricate dynamics of pharmacological interventions in mental health and psychiatry. With an ISSN of 0269-8811 and an E-ISSN of 1461-7285, this esteemed journal has established its reputation in the field since its inception in 1987, converging research excellence into 2024. Recognized as a Q1 journal in various categories including Medicine (miscellaneous), Pharmacology, and Psychiatry and Mental Health, it ranks impressively within the top percentile in Scopus, standing at #64 out of 567 in Psychiatry and Mental Health, and #31 out of 272 in Medical Pharmacology. The journal serves as a vital resource for researchers, professionals, and students, providing insightful articles that advance the understanding of psychopharmacological effects and innovations. Although it does not offer open access, the journal's extensive research and impactful findings make it essential reading for anyone engaged in the field. For those seeking to stay at the forefront of psychopharmacology, the JOURNAL OF PSYCHOPHARMACOLOGY is an invaluable asset.

Iranian Journal of Psychiatry and Behavioral Sciences, published by BRIEFLAND, is a pivotal platform for scholars and practitioners in the fields of psychiatry and behavioral sciences. With its ISSN 1735-8639 and E-ISSN 1735-9287, this journal primarily caters to the Iranian context while fostering a global dialogue on contemporary issues in mental health, behavioral neurology, and biological psychiatry. Since its inception in 2007, the journal has committed to disseminating high-quality research and reviews, thereby contributing to its categorization in the fourth quartile (Q4) for both Behavioral Neuroscience and Biological Psychiatry as of 2023. Although currently lacking an open access model, the journal's accessibility to critical research discussions is vital for enhancing knowledge among researchers, professionals, and students alike. With emerging relevance in the Iranian mental health landscape, it aims to bridge gaps in understanding and promote evidence-based practices from 2007 to 2024 and beyond.

JOURNAL OF PSYCHOSOMATIC RESEARCH, published by Pergamon-Elsevier Science Ltd, stands as a premier international forum dedicated to the integration of psychological and physical health. Established in 1956, this esteemed journal has maintained a high impact in the field, currently ranking in the Q1 category for both Clinical Psychology and Psychiatry and Mental Health as of 2023. With an impressive Scopus ranking of #37/311 in Clinical Psychology and #95/567 in Psychiatry and Mental Health, it caters to a wide audience of researchers, clinicians, and students interested in the complex interplay between psychosocial factors and physical health outcomes. The journal publishes a diverse array of original research, reviews, and clinical studies, providing valuable insights into psychosomatic medicine. While it currently does not offer open access options, its robust editorial standards ensure that each publication contributes significantly to advancing the field. As the journal converges into its 68th year, it continues to be at the forefront of psychosomatic research, instrumental in shaping evidence-based practices and enhancing patient care.

Psychotherapie is a pivotal academic journal dedicated to the exploration and advancement of clinical psychology, published by the esteemed Springer. Since its inception in 2022, this journal has established a significant footprint in the field, currently positioned in the Q3 category for Clinical Psychology in 2023, as well as being recognized for its Scopus ranking within the top half of its category. This valuable resource features a broad scope of peer-reviewed articles aimed at both theoretical and practical developments in psychotherapy, making it a vital platform for researchers, professionals, and students alike. While the journal is not open access, it maintains a commitment to disseminating high-quality research that can influence best practices and contribute to the ongoing discourse in psychology. The journal's editorial objective is to connect scientific research with clinical practice, ensuring insights garnered from emerging studies are readily available to enhance therapeutic outcomes. Located in the USA with a strong presence in Germany, Psychotherapie promises to be an essential resource for anyone keen on innovative therapeutical approaches and psychological research.

Psycho-Oncologie is a specialized academic journal dedicated to the intersection of psychology and oncology, published by TECH SCIENCE PRESS. With an ISSN of 1778-3798 and E-ISSN of 1778-381X, this journal serves as an important platform for researchers and practitioners seeking to understand the psychological impact of cancer on patients and their families. Established in 2007 and converging with its findings through 2024, Psycho-Oncologie aims to disseminate high-quality research that enhances mental health and promotes effective treatment strategies within the oncological landscape. Although currently holding a Q4 ranking in disciplines such as Clinical Psychology and Oncology, the journal is committed to maintaining a high standard of research integrity and scientific rigor to foster future advancements. Although it operates under a non-open access model, the journal strives to make its valuable insights available to a broader audience. For those in the fields of psychology, oncology, and health care, Psycho-Oncologie is an essential resource for staying abreast of critical developments and contributing to interdisciplinary approaches in cancer treatment.

Psychology of Consciousness-Theory Research and Practice, published by the Educational Publishing Foundation, American Psychological Association, serves as a pivotal platform for innovative research at the intersection of psychological theory and practical application. With its ISSN 2326-5523 and E-ISSN 2326-5531, this journal has established itself as a significant contributor to the field since its inception in 2016, continuing to shape discussions on consciousness through diverse psychological lenses. Recognized in 2023 with prestigious rankings such as Q2 in Clinical Psychology and Q2 in Social Psychology, it features rigorous studies that resonate widely among scholars and practitioners alike. Notable for its commitment to open discourse, although not open access, the journal encourages the exchange of ideas while maintaining high academic standards. Researchers and students will find invaluable insights into consciousness studies, informed by the latest empirical findings and theoretical developments, bolstering the journal's reputation as an essential resource for those dedicated to advancing the science of psychology.

SCHMERZ is a pivotal journal in the fields of anesthesiology, pain medicine, and clinical neurology, published by SPRINGER HEIDELBERG in Germany. With an ISSN of 0932-433X and an E-ISSN of 1432-2129, the journal is celebrated for its rigorous peer-reviewed articles contributing to the understanding and management of pain. Since its inception in 1987, SCHMERZ has developed an impressive readership, ranking in the Q3 category across multiple disciplines, including Anesthesiology and Pain Medicine, and Clinical Neurology. Operating within the 50th percentile for anesthesiology and the 32nd percentile in neurology, the journal stands as a critical resource for practitioners, researchers, and students engaging with current trends and advancements in pain research and treatment. While not currently offering open access options, SCHMERZ continues to strive toward disseminating high-quality research and fostering vital discussions in the management of pain. With a scope that aims to bridge clinical practices with scientific understanding, SCHMERZ invites contributions that will illuminate and advance the multifaceted nature of pain and its treatment.